Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Encouraging results for Bayer’s targeted radionuclide therapy 225Ac ...
225 Ac/ 213 Bi radionuclide generators for the separation of 213 Bi ...
Frontiers | Alpha-peptide receptor radionuclide therapy using actinium ...
Leveraging Bioorthogonal Click Chemistry to Improve 225Ac ...
225Ac-MACROPATATE: A Novel α-Particle Peptide Receptor Radionuclide ...
(PDF) Peptide Receptor Radionuclide Therapy Using 225Ac-DOTATOC ...
Radionuclide Prostate Membrane Antigen 225Ac-J591 & 177Lu-PSMA I&T ...
Sequential 177Lu/225Ac-LNC1004 targeted radionuclide therapy with anti ...
Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac ...
(PDF) Advances in 177Lu-PSMA and 225Ac-PSMA Radionuclide Therapy for ...
Targeted Radionuclide Therapy of Prostate Cancer—From Basic Research to ...
Peptide Receptor Radionuclide Therapy Using 225Ac-DOTATOC Ac ...
Advances in 177Lu-PSMA and 225Ac-PSMA Radionuclide Therapy for ...
Bayer starts Phase I study with novel targeted radionuclide therapy ...
225Ac-FL-020 is a novel PSMA-targeting radionuclide drug conjugate (RDC ...
Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies ...
Extrapolating organ and tumor doses for 225Ac-PSMA-I&T radionuclide ...
Alpha-peptide receptor radionuclide therapy using actinium-225 labeled ...
TAG-72–Targeted α-Radionuclide Therapy of Ovarian Cancer Using 225Ac ...
Enhanced Radionuclide Therapy via the Conjugation of Pentadecanoic ...
(PDF) 225 Ac/ 213 Bi radionuclide generators for the separation of 213 ...
(PDF) Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside
Radionuclide conjugates 225Ac-J591 and 177Lu-PSMA-I&T for mCRPC ...
Figure 1 from Realizing the potential of the Actinium-225 radionuclide ...
225Ac/213Bi radionuclide generators for the separation of 213Bi towards ...
(a) Chemical structure of DKFZ-PSMA-617 (Sharifi et al., 2016). 225Ac ...
Calcium Carbonate Core–Shell Particles for Incorporation of 225Ac and ...
Targeted Alpha Therapy: All We Need to Know about 225Ac’s Physical ...
Production Routes | Actineer
Ac-225 Chloride (NCA) » medisynt
Radionuclides
Actinium-225 - BWXT Medical Ltd. | Innovation in Nuclear Medicine ...
Actinium-225 targeted alpha particle therapy for prostate cancer - PMC
AUA 2024: Phase I Dose-Escalation Trial of Multiple and Fractionated ...
Gamma spectrum for various 225 Ac samples: (a) 225 Ac product (initial ...
Figure 2 from First In Vivo and Phantom Imaging of Cyclotron-Produced ...
ASCO 2025: PSMA-Targeted Actinium-225 Therapy in Metastatic Castration ...
Development of [225Ac]Ac-PSMA-I&T for Targeted Alpha Therapy According ...
ESMO 2025: Dose-Escalation + Expansion Trial of Fractionated and ...
225Ac-Labeled Somatostatin Analogs in the Management of Neuroendocrine ...
Figure 1 from 225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of ...
ASCO 2023: Phase I Dose-Escalation Results of PSMA Targeted ...
[225Ac]Ac-PSMA for the Treatment of Metastatic Castration-Resistant ...
Efficient 1-Step Radiolabeling of Monoclonal Antibodies to High ...
PD01-11: Phase I Dose-Escalation Trial of Multiple and Fractionated ...
Actinium-225 targeted alpha particle therapy for prostate cancer
Production and Supply of α-Particle–Emitting Radionuclides for Targeted ...
[225Ac]Ac-SibuDAB for Targeted Alpha Therapy of Prostate Cancer ...
Real-time trajectory imaging of alpha particles emitted from actinium ...
Tandem Isotope Therapy with 225Ac- and 177Lu-PSMA-617 in a Murine Model ...
Synthesis and preliminary evaluation of [225Ac]Ac‑LNC1011 for targeted ...
By Shukurov R.
Th-229 and Ac-225 decay chain. Radionuclide, half-life, emission and ...
Decay scheme of 225 Ac | Download Scientific Diagram
First In Vivo and Phantom Imaging of Cyclotron-Produced 133La as a ...
Comparison of Biological Effects of 177Lu, 225Ac, and 161Tb in Targeted ...
Recent Innovations and Nano-Delivery of Actinium-225: A Narrative Review
The relative amount of the separated radionuclides 223 Ra and 225 Ac as ...
Radiochemical yields (RCY, %) for 225 Ac III radiolabeling reactions of ...
Radium-223 and Actinium-225 α-Emitter Radiopharmaceuticals in Treatment ...
Treatment of Patients with Acute Myeloid Leukemia with the Targeted ...
Labeling process and quality control results of 225Ac-PSMA-617 for ...
Essentials of Theranostics: A Guide for Physicians and Medical ...
Recent advances in the development of 225Ac- and 211At-labeled ...
(1) Schematic illustration of the formation of sub-micron 225 Ac-doped ...
Targeted radioligand therapy: physics and biology, internal dosimetry ...
(PDF) Selective separation of Bi3+ from La3+/Ac3+ by sorption on ...
Preclinical evaluation of [225Ac]Ac-crown-TATE – an alpha-emitting ...
Structural formula of [ 225 Ac]Ac-PSMA-I&T, with DOTAGA as a chelator ...
Impact of radiopharmaceutical therapy (177Lu, 225Ac) microdistribution ...
Signaling Network Response to α-Particle–Targeted Therapy with the ...
225Ac-rHDL Nanoparticles: A Potential Agent for Targeted Alpha-Particle ...
Ionetix to provide Bayer with Therapeutic Radioisotope Actinium-225 (Ac ...
Dosimetric impact of Ac-227 in accelerator-produced Ac-225 for alpha ...
